Amerilab Technologies

Executive Summary

Amerilab Technologies is a privately held contract manufacturing organization (CMO) based in Plymouth, Minnesota, with over 25 years of expertise in effervescent tablets and powders, as well as non-effervescent powders. Founded in 1990, the company provides end-to-end turnkey services, including development, production, and packaging of custom formulations for clients in the nutraceutical and pharmaceutical sectors. Its recent addition of a production line capable of combining multiple stick flavors underscores a commitment to product customization and innovation. As a long-standing industry player, Amerilab is well-positioned to benefit from growing demand for effervescent drug delivery systems, which offer advantages in patient compliance and bioavailability. However, due to its private status, limited public financial data is available, making it challenging to assess near-term performance. The company's success hinges on securing new contracts, expanding capacity, and maintaining its reputation for quality and reliability. With a solid track record and a niche focus, Amerilab is a stable but low-visibility player in the CMO landscape.

Upcoming Catalysts (preview)

• Q3 2026New large-scale contract with a major pharmaceutical or nutraceutical company50% success
• 2026Manufacturing capacity expansion announcement65% success
• TBDLaunch of proprietary effervescent platform technology30% success